Program
Preliminary program subject to change.
Topics:
1. Deep Brain Stimulation (DBS)
2. Electroconvulsive Therapy (ECT)
3. Epidural Cortical Stimulation and Microstimulation
4. Transcranial Ultrasound Stimulation (tUS) / Low Intensity Focused Ultrasound (LIFU)
5. Pulsed Ultrasound (pUS)
6. High Intensity Focused Ultrasound (HIFU)
7. Transcranial Magnetic Stimulation (TMS)
8. Transcranial Alternating Current Stimulation (tACS)
9. Transcranial Direct Current Stimulation (tDCS)
10. Transcranial Random Noise Stimulation (tRNS)
11. Vagus Nerve Stimulation (VNS) and Cranial Nerve Stimulation
12. Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS)
13. Transcranial photobiomodulation (tPBM) and Light Based Neuromodulation
14. Temporal Interference Stimulation
15. Neuroprostheses / Functional Electrical Stimulation
16. Focal Pharmacology
17. Brain-computer Interfaces and bidirectional BC
18. Other Techniques
Experimental Models (Optional)
19. Modeling and computational methods
20. Cellular / in vitro Mechanisms of Stimulation
21. Preclinical models
22. Electroencephalography (EEG) / Magnetoencephalography (MEG)
23. Electromyography (EMG)
24. Functional Brain Imaging
25. Structural Brain Imaging
26. Hardware / Power / Electrode Design
27. Neuronavigation
Purpose / Application (Optional)
28. Focal Pharmacology
29. Responsive (Closed-Loop) Stimulation
30. Brain-computer Interfaces and bidirectional BC
31. Neuroprostheses
32. Neurorehabilitation
33. Neuropharmacology
34. Neurophysiology
35. Neuroplasticity
36. Neuropsychology
Industry Sponsored Workshops
Registration for these industry sponsor workshops will open shortly. Sunday, 21 February 2027, 10:00 a.m. - 17:00 p.m. Soterix Medical
Advanced Neuromodulation and Neuromonitoring Training Workshop with Updates on the Latest Technologies The workshop will focus on fundamentals and advanced applications of non-invasive neuromodulation and neuromonitoring technologies, with in-depth product demonstrations and hands-on training.
Topics include:
Conventional and High Definition transcranial Electrical Stimulation (tES/HD-tES)
Remote Supervised tDCS/tES and HD-tES
Our first hybrid HD-tES and EEG solution (MXN-GO EEG)
Temporal Interference (TI) / Interferential Stimulation (IFS)
Repetitive transcranial Magnetic Stimulation (rTMS) with Soterix Medical SPRY TMS and Neuronavigation
Transcranial-focused Ultrasound Stimulation (tFUS)
Galvanic Vestibular Stimulation (GVS), transcutaneous Auricular Vagus Nerve
Stimulation (taVNS), and closed-loop transcranial Electrical Stimulation (tES) and monitoring
New and upcoming technologies
Register hereopens in new tab/window
Sunday, 21 February 2027 MagVenture Theme: Next wave of convulsive therapy using MagVenture MST Technology Join leading experts and early pioneers in Magnetic Seizure Therapy (MST) for a unique full-day educational and training experience. The two workshops have been intentionally designed as a connected program, with the morning session providing the clinical and scientific foundation that naturally flows into the hands-on certification workshop in the afternoon.
We strongly encourage participants to attend both sessions to gain the full educational and practical MST experience.
Attend the full-day MST experience: Learn the science in the morning. Gain certification and practical expertise in the afternoon.
Morning session from 10:00 to 13:00 – Free: Education in MST — the next wave of convulsive therapy using Non-invasive Electromagnetic Ultra Rapid Onset Neuromodulation Therapy.
This educational session will explore the science, clinical evidence, and future potential of Magnetic Seizure Therapy (MST), an emerging next-generation convulsive therapy platform.
Afternoon Session from 14:00 to 17:00 - Registration fee 399€ : MST Early Pioneer Training & Technology Certification - hands on session
Building directly on the concepts covered during the morning session, the afternoon workshop provides an immersive training experience for clinicians and researchers interested in becoming early adopters of MST technology.
Registration: www.conferencemanager.dk/magventuremstopens in new tab/window
Sunday, 21 February 2027, 14:00 p.m. - 17:00 p.m. BRAINBOX
Monday, 22 February 2027, 7:30 a.m. - 8:30 a.m. MagVenture Next-gen TMS technology — personalization, accelerated, precision-enabled TMS https://marketing.magventure.com/IBS_MagVenture_workshop_1opens in new tab/window
Monday, 22 February 2027, 7:30 a.m. - 8:30 a.m. Sigmastim
ECT Barriers to Treatment: Why is it difficult for most patients to access ECT?
This workshop will will begin with an account from Ted Scheinman, the Senior Editor of Smithsonian Magazine, and the author of the new book, Jolt, a riveting account of depression, memory and ECT. His story will be followed up by four international ECT clinicians, who will discuss the barriers to treatment in their own countries: USA, Canada, Australia and Ireland. A light breakfast will be served.
Register here opens in new tab/window
Monday, 22 February 2027, 7:30 a.m. - 8:30 a.m. Vielight
Tuesday, 23 February 2027, 7:30 a.m. - 8:30 a.m. MagVenture Future of convulsive therapy — MST (MagVenture NEURON™ Therapy) https://marketing.magventure.com/IBS_MagVenture_workshop_2opens in new tab/window
Tuesday, 23 February 2027, 7:30 a.m. - 8:30 a.m. MagVenture Future of convulsive therapy — MST (MagVenture NEURON™ Therapy)
Tuesday, 23 February 2027, 7:30 - 8:30a.m. Livanova Implementing VNS Therapy for Difficult to Treat Depression in Clinical Practice - Practical Experience and Best Practice
This clinical workshop explores the practical implementation of implantable Vagus Nerve Stimulation (VNS) Therapy for patients with difficult‑to‑treat depression. Drawing on expert consensus statements and real‑world clinical experience and the latest data from the RECOVER randomised control trial, the session will address patient selection, treatment pathways and long‑term management. Best‑practice recommendations will be discussed, alongside case examples illustrating common challenges and solutions, to support clinicians in safely and effectively integrating VNS Therapy into routine clinical practice.
Wednesday, 24 February 2027, 7:30 - 8:30a.m. STORZ MEDICAL Transcranial Pulse Stimulation (TPS) for Non-Invasive Brain Stimulation: Latest Advances and Future Directions
Transcranial Pulse Stimulation (TPS) is an innovative treatment for patients with Alzheimer’s dementia, utilizing low-energy acoustic pulse waves to target affected brain regions.
The NEUROLITH device, CE-approved since 2018, is designed for TPS treatment and delivers energy non-invasively, reaching depths of up to 8 centimetres. A standard TPS treatment protocol involves six sessions within two weeks, with each session lasting approximately 30 minutes. Follow-up sessions are tailored individually, typically scheduled 4 to 8 weeks after the initial treatment series. The TPS application is visually monitored, enabling real-time tracking of targeted brain areas, ensuring accuracy and safety.